Pauwels, Elin
Cleeren, Frederik
Tshibangu, Térence
Koole, Michel
Serdons, Kim
Dekervel, Jeroen
Van Cutsem, Eric
Verslype, Chris
Van Laere, Koen
Bormans, Guy
Deroose, Christophe M. http://orcid.org/0000-0002-6080-1577
Article History
Received: 24 May 2019
Accepted: 2 July 2019
First Online: 31 July 2019
Compliance with ethical standards
:
: Eric Van Cutsem has received research grants and personal fees for consultancy from Amgen, Bayer, Boehringer Ingelheim, Celgene, Ipsen, Lilly, Roche, Merck Sharp & Dohme, Merck KGaA, Novartis, Roche and Servier. Chris Verslype has received research grants and performed consultancy services for Novartis and Ipsen. Koen Van Laere has performed consultancy services and contract research through KU Leuven for GE Healthcare, Merck, Janssen Pharmaceuticals, UCB, Syndesi Therapeutics and Eikonizo. Guy Bormans has performed funded contract research with Eikonizo, Merck, Celgene, Janssen Pharmaceuticals and UCB. Christophe M. Deroose has been a consultant for Novartis, Terumo, AAA, Ipsen, Sirtex, and Bayer outside the scope of the submitted work. There are no other conflicts of interest.
: All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Ethische Commissie Onderzoek UZ/KU Leuven S61727) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the prospective clinical study (NCT03883776), including the patient presented in this case report. A separate consent from the patient was obtained for publication of the case report.